Background and objectives One year after the onset of the coronavirus disease 2019 (COVID-19)
pandemic, we aimed to summarize the frequency of neurologic manifestations …

Galantamine hydrobromide, a promising acetylcholinesterase inhibitor is reported to be
associated with cholinergic side effects. Its poor brain penetration results in lower bioavailability …

Neuroinflammation is a prominent feature of Alzheimer disease (AD) and other chronic
neurodegenerative disorders. Intracerebroventricular (ICV) streptozotocin (STZ) induced-…

Introduction: Alzheimer's disease (AD) is a daunting public health threat that has prompted
the scientific community's ongoing efforts to decipher the underlying disease mechanism, and …

The role of lipoprotein-A [Lp (a)] as a risk factor for stroke is less well documented than for
coronary heart disease. Hence, we conducted a systematic review and meta-analysis for the …

Computed tomography (CT) scan is the mainstay for diagnosis of stroke; but the facility of CT
scan is not easily available. A blood‐based biomarker approach is required to distinguish …

Background Correct diagnosis of stroke and its subtypes is pivotal in early stages for optimum
treatment. Aims The aim of this systematic review and meta-analysis is to summarize the …

Importance Published data about the impact of poststroke seizures (PSSs) on the outcomes
of patients with stroke are inconsistent and have not been systematically evaluated, to the …

Introduction: The molecular pathogenesis of Alzheimer's disease (AD) includes a variety of
risk factors, extracellular deposition of β-amyloid, accumulation of intracellular neurofibrillary …

Background Ischemic stroke (IS) is a complex and devastating vascular disease that has
become one of the leading causes of disability and mortality worldwide. Several studies have …